You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Sickle Cell Disease Drug Market Insights and Forecast to 2026

Market Analysis and Insights: Global Sickle Cell Disease Drug Market
Prior to COVID-19, the market for Sickle Cell Disease Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Sickle Cell Disease Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Sickle Cell Disease Drug market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sickle Cell Disease Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Sickle Cell Disease Drug industry.
Global Sickle Cell Disease Drug Scope and Segment
Sickle Cell Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc
Sickle Cell Disease Drug Breakdown Data by Type
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
Sickle Cell Disease Drug Breakdown Data by Application
Hospital
Clinic
Others
Regional and Country-level Analysis
The Sickle Cell Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sickle Cell Disease Drug market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Sickle Cell Disease Drug Market Share Analysis
1 Study Coverage
1.1 Sickle Cell Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Sickle Cell Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Type
1.4.2 ARQ-092
1.4.3 BIVV-003
1.4.4 CAL-H
1.4.5 CTX-001
1.4.6 DRX-194
1.4.7 Others
1.5 Market by Application
1.5.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Sickle Cell Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Sickle Cell Disease Drug Revenue 2015-2026
2.1.2 Global Sickle Cell Disease Drug Sales 2015-2026
2.2 Global Sickle Cell Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sickle Cell Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sickle Cell Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Sickle Cell Disease Drug Competitor Landscape by Players
3.1 Sickle Cell Disease Drug Sales by Manufacturers
3.1.1 Sickle Cell Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Sickle Cell Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Sickle Cell Disease Drug Revenue by Manufacturers
3.2.1 Sickle Cell Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Sickle Cell Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sickle Cell Disease Drug Revenue in 2019
3.2.5 Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sickle Cell Disease Drug Price by Manufacturers
3.4 Sickle Cell Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Sickle Cell Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sickle Cell Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Sickle Cell Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sickle Cell Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Sickle Cell Disease Drug Sales by Type (2015-2020)
4.1.2 Global Sickle Cell Disease Drug Revenue by Type (2015-2020)
4.1.3 Sickle Cell Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sickle Cell Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Sickle Cell Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Sickle Cell Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sickle Cell Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Sickle Cell Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Sickle Cell Disease Drug Sales by Application (2015-2020)
5.1.2 Global Sickle Cell Disease Drug Revenue by Application (2015-2020)
5.1.3 Sickle Cell Disease Drug Price by Application (2015-2020)
5.2 Sickle Cell Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Sickle Cell Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Sickle Cell Disease Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Sickle Cell Disease Drug by Country
6.1.1 North America Sickle Cell Disease Drug Sales by Country
6.1.2 North America Sickle Cell Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sickle Cell Disease Drug Market Facts & Figures by Type
6.3 North America Sickle Cell Disease Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Sickle Cell Disease Drug by Country
7.1.1 Europe Sickle Cell Disease Drug Sales by Country
7.1.2 Europe Sickle Cell Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sickle Cell Disease Drug Market Facts & Figures by Type
7.3 Europe Sickle Cell Disease Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Sickle Cell Disease Drug by Region
8.1.1 Asia Pacific Sickle Cell Disease Drug Sales by Region
8.1.2 Asia Pacific Sickle Cell Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Sickle Cell Disease Drug by Country
9.1.1 Latin America Sickle Cell Disease Drug Sales by Country
9.1.2 Latin America Sickle Cell Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sickle Cell Disease Drug Market Facts & Figures by Type
9.3 Central & South America Sickle Cell Disease Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Sickle Cell Disease Drug by Country
10.1.1 Middle East and Africa Sickle Cell Disease Drug Sales by Country
10.1.2 Middle East and Africa Sickle Cell Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
11.2 Addmedica SAS
11.2.1 Addmedica SAS Corporation Information
11.2.2 Addmedica SAS Description and Business Overview
11.2.3 Addmedica SAS Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Addmedica SAS Sickle Cell Disease Drug Products Offered
11.2.5 Addmedica SAS Related Developments
11.3 Angiocrine Bioscience Inc
11.3.1 Angiocrine Bioscience Inc Corporation Information
11.3.2 Angiocrine Bioscience Inc Description and Business Overview
11.3.3 Angiocrine Bioscience Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Products Offered
11.3.5 Angiocrine Bioscience Inc Related Developments
11.4 Annexin Pharmaceuticals AB
11.4.1 Annexin Pharmaceuticals AB Corporation Information
11.4.2 Annexin Pharmaceuticals AB Description and Business Overview
11.4.3 Annexin Pharmaceuticals AB Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Products Offered
11.4.5 Annexin Pharmaceuticals AB Related Developments
11.5 ArQule Inc
11.5.1 ArQule Inc Corporation Information
11.5.2 ArQule Inc Description and Business Overview
11.5.3 ArQule Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ArQule Inc Sickle Cell Disease Drug Products Offered
11.5.5 ArQule Inc Related Developments
11.6 Bio Products Laboratory Ltd
11.6.1 Bio Products Laboratory Ltd Corporation Information
11.6.2 Bio Products Laboratory Ltd Description and Business Overview
11.6.3 Bio Products Laboratory Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Products Offered
11.6.5 Bio Products Laboratory Ltd Related Developments
11.7 Bioverativ Inc
11.7.1 Bioverativ Inc Corporation Information
11.7.2 Bioverativ Inc Description and Business Overview
11.7.3 Bioverativ Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bioverativ Inc Sickle Cell Disease Drug Products Offered
11.7.5 Bioverativ Inc Related Developments
11.8 bluebird bio Inc
11.8.1 bluebird bio Inc Corporation Information
11.8.2 bluebird bio Inc Description and Business Overview
11.8.3 bluebird bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 bluebird bio Inc Sickle Cell Disease Drug Products Offered
11.8.5 bluebird bio Inc Related Developments
11.9 Bristol-Myers Squibb Co
11.9.1 Bristol-Myers Squibb Co Corporation Information
11.9.2 Bristol-Myers Squibb Co Description and Business Overview
11.9.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Products Offered
11.9.5 Bristol-Myers Squibb Co Related Developments
11.10 Calimmune Inc
11.10.1 Calimmune Inc Corporation Information
11.10.2 Calimmune Inc Description and Business Overview
11.10.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Calimmune Inc Sickle Cell Disease Drug Products Offered
11.10.5 Calimmune Inc Related Developments
11.1 Acceleron Pharma Inc
11.1.1 Acceleron Pharma Inc Corporation Information
11.1.2 Acceleron Pharma Inc Description and Business Overview
11.1.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
11.1.5 Acceleron Pharma Inc Related Developments
11.12 CSL Ltd
11.12.1 CSL Ltd Corporation Information
11.12.2 CSL Ltd Description and Business Overview
11.12.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CSL Ltd Products Offered
11.12.5 CSL Ltd Related Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Corporation Information
11.13.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.13.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Daiichi Sankyo Co Ltd Products Offered
11.13.5 Daiichi Sankyo Co Ltd Related Developments
11.14 Editas Medicine Inc
11.14.1 Editas Medicine Inc Corporation Information
11.14.2 Editas Medicine Inc Description and Business Overview
11.14.3 Editas Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Editas Medicine Inc Products Offered
11.14.5 Editas Medicine Inc Related Developments
11.15 Errant Gene Therapeutics LLC
11.15.1 Errant Gene Therapeutics LLC Corporation Information
11.15.2 Errant Gene Therapeutics LLC Description and Business Overview
11.15.3 Errant Gene Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Errant Gene Therapeutics LLC Products Offered
11.15.5 Errant Gene Therapeutics LLC Related Developments
11.16 Gamida Cell Ltd
11.16.1 Gamida Cell Ltd Corporation Information
11.16.2 Gamida Cell Ltd Description and Business Overview
11.16.3 Gamida Cell Ltd Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Gamida Cell Ltd Products Offered
11.16.5 Gamida Cell Ltd Related Developments
11.17 Genethon SA
11.17.1 Genethon SA Corporation Information
11.17.2 Genethon SA Description and Business Overview
11.17.3 Genethon SA Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Genethon SA Products Offered
11.17.5 Genethon SA Related Developments
11.18 Gilead Sciences Inc
11.18.1 Gilead Sciences Inc Corporation Information
11.18.2 Gilead Sciences Inc Description and Business Overview
11.18.3 Gilead Sciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Gilead Sciences Inc Products Offered
11.18.5 Gilead Sciences Inc Related Developments
11.19 Global Blood Therapeutics Inc
11.19.1 Global Blood Therapeutics Inc Corporation Information
11.19.2 Global Blood Therapeutics Inc Description and Business Overview
11.19.3 Global Blood Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Global Blood Therapeutics Inc Products Offered
11.19.5 Global Blood Therapeutics Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sickle Cell Disease Drug Market Estimates and Projections by Region
12.1.1 Global Sickle Cell Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Sickle Cell Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sickle Cell Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sickle Cell Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sickle Cell Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sickle Cell Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sickle Cell Disease Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Sickle Cell Disease Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sickle Cell Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2020
  • NO OF PAGES: 126